Human Glioma Immunobiology in Vitro: Implications for Immunogene Therapy
- 1 May 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 46 (5) , 1169-1178
- https://doi.org/10.1097/00006123-200005000-00030
Abstract
OBJECTIVE. Human gliomas are known to be immunosuppressive. Recent reports have suggested novel strategies to overcome this immunosuppression, includinKeywords
This publication has 55 references indexed in Scilit:
- The expanding universe of T-cell subsets: Th1, Th2 and morePublished by Elsevier ,1999
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Mechanisms of Lysis by Cytotoxic T CellsCritical Reviews in Immunology, 1995
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Selective expression of interleukin-10 gene within glioblastoma multiformeBrain Research, 1994
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- Molecular Mechanisms Used by Tumors to Escape Immune RecognitionJournal of Immunotherapy, 1993
- Modulation of T-cell function by gliomasImmunology Today, 1991
- Characterization of four human malignant glioma cell linesActa Neuropathologica, 1985
- Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigensEuropean Journal of Cancer and Clinical Oncology, 1985